Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sorrento Therapeutics (SRNE)
NASDAQ:SRNE
RESEARCH TOOLSreports
Sorrento Therapeutics (SRNE) Financial Statements
0 Followers
Sorrento Therapeutics Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 17.40M | $ 11.46M | $ 18.39M | $ 13.08M | $ 12.06M |
| Gross Profit | $ 9.13M | $ 5.76M | $ 12.63M | $ 9.94M | $ 8.68M |
| EBIT | $ -90.91M | $ -218.28M | $ -35.70M | $ -175.13M | $ -116.87M |
| EBITDA | $ -87.55M | $ -215.05M | $ -32.40M | $ -172.27M | $ -113.33M |
| Net Income Common Stockholders | $ -89.58M | $ -218.76M | $ -40.81M | $ -144.42M | $ -119.80M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 117.86M | $ 133.60M | $ 270.66M | $ 126.88M | $ 162.67M |
| Total Assets | $ 615.61M | $ 632.13M | $ 855.64M | $ 694.82M | $ 752.79M |
| Total Debt | $ 168.21M | $ 204.61M | $ 248.88M | $ 237.58M | $ 202.56M |
| Net Debt | $ 50.35M | $ 71.00M | $ -21.77M | $ 110.69M | $ 39.89M |
| Total Liabilities | $ 485.41M | $ 496.37M | $ 629.44M | $ 616.69M | $ 621.46M |
| Stockholders Equity | $ 131.85M | $ 132.02M | $ 226.54M | $ 78.75M | $ 131.50M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -65.01M | $ -83.69M | $ -85.95M | $ -74.35M | $ -84.29M |
| Operating Cash Flow | $ -61.17M | $ -80.99M | $ -83.36M | $ -72.14M | $ -83.11M |
| Investing Cash Flow | $ -8.09M | $ -1.73M | $ -13.66M | $ -2.21M | $ 5.40M |
| Financing Cash Flow | $ 71.50M | $ 41.77M | $ 173.37M | $ 70.86M | $ 40.06M |
Sorrento Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.